The FDA warned healthcare workers and pharmacies on Feb. 9 not to use an unapproved potassium phosphates drug made by Hospira, a Pfizer company, in pediatric patients because the aluminum exposure can be up to double the agency’s limit.
Read the full post on Becker's Hospital Review - Healthcare News
